Albert W. Garofalo
Escape Therapeutics (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Monoclonal and Polyclonal Antibodies Research, Oxidative Organic Chemistry Reactions
Most-Cited Works
- → Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes(2014)210 cited
- → Oxidative cleavage of mono-, di-, and trisubstituted olefins to methyl esters through ozonolysis in methanolic sodium hydroxide(1993)107 cited
- → Antihyperglycemic Activities of Cryptolepine Analogues: An Ethnobotanical Lead Structure Isolated fromCryptolepis sanguinolenta(1998)104 cited
- → Generating Site-Specifically Modified Proteins via a Versatile and Stable Nucleophilic Carbon Ligation(2015)66 cited
- → Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease(2010)50 cited
- → Site-Specific Tandem Knoevenagel Condensation–Michael Addition To Generate Antibody–Drug Conjugates(2016)50 cited
- → Selective Inhibitors of G2019S-LRRK2 Kinase Activity(2020)45 cited
- → Synthesis of Chiral α,δ-Dioxygenated Allylic Stannanes as Reagents for Carbohydrate Synthesis and Homologation(1996)44 cited
- → Exploring the effects of linker composition on site-specifically modified antibody–drug conjugates(2014)39 cited
- → Novel cinnoline-based inhibitors of LRRK2 kinase activity(2012)39 cited